---
title: "Pacibekitug, an IL-6 antibody, lowered inflammation in Phase 2 TRANQUILITY — implications for hear"
id: "stat-news-0-stat-a-novartis-drug-cut-inflammation-can-it-improve-heart-outcomes"
canonical_url: "https://medichelpline.com/clinical-feed/stat-news-0-stat-a-novartis-drug-cut-inflammation-can-it-improve-heart-outcomes"
content_type: "clinical_feed_article"
specialty: "Cardiology"
source_name: "STAT News"
source_url: "https://www.statnews.com/2026/08/29/novartis-pacibekitug-inflammation-il6-tourmaline-heart-disease/?utm_campaign=rss"
published_at: "2026-08-29T07:32:11.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Pacibekitug, an IL-6 antibody, lowered inflammation in Phase 2 TRANQUILITY — implications for hear
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/stat-news-0-stat-a-novartis-drug-cut-inflammation-can-it-improve-heart-outcomes
- **Specialty:** [Cardiology](https://medichelpline.com/clinical-feed/cardiology.md)
- **Primary Source:** STAT News
- **Source URL:** [Original Journal Publication](https://www.statnews.com/2026/08/29/novartis-pacibekitug-inflammation-il6-tourmaline-heart-disease/?utm_campaign=rss)
- **Published At:** 2026-08-29T07:32:11.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- A newly acquired Novartis antibody, **pacibekitug**, produced sustained reductions in **inflammation** biomarkers in a midstage (Phase 2) study called TRANQUILITY, according to results presented at the European Society of Cardiology annual meeting in Munich. - Investigators reported a **dose-dependent** fall in biomarker levels on certain measures, indicating higher doses produced greater reductions and suggesting target engagement. - Pacibekitug is an antibody directed against **IL-6 (interleukin-6)**, a cytokine involved in immune regulation and a shared inflammatory driver implicated in cardiovascular risk. - The reported data come from a midstage trial; the article notes the results were presented publicly but is behind a STAT+ paywall, and many trial details were not provided in the accessible portion of the source. - The company and external experts are awaiting Novartis’s plans for advancing the drug toward potential **cardiovascular** indications; the article emphasizes uncertainty about whether inflammation lowering will translate into improved heart outcomes. - The source reported the study was presented at the ESC meeting in Munich and characterized the reductions as sustained, but did not provide specific biomarker names, numerical effect sizes, patient numbers, safety data, or cardiovascular event results in the accessible text. - Overall, the report frames pacibekitug as biologically active against a key inflammatory pathway but highlights that proof of clinical benefit for heart disease remains unreported and is pending further development and data disclosure.
## Clinical Analysis & Structured Key Points
[Skip to Main Content](https://www.statnews.com/2026/08/29/novartis-pacibekitug-inflammation-il6-tourmaline-heart-disease/?utm_campaign=rss#wrapper) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo-white.svg) ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * Email this article * [Share this article](https://www.statnews.com/2026/08/29/novartis-pacibekitug-inflammation-il6-tourmaline-heart-disease/?utm_campaign=rss) [research](https://www.statnews.com/topic/research/) [Physicians](https://www.statnews.com/topic/physicians/) [Mental Health](https://www.statnews.com/topic/mental-health/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) My Account * [Settings Complete your personal information for a more tailored experience ](https://www.statnews.com/my-account/) * [Billing](https://www.statnews.com/my-account/billing/) * [Log In](https://www.statnews.com/login/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) Reporting from the frontiers of health and medicine ](https://www.statnews.com/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Public Health](https://www.statnews.com/category/health/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Policy](https://www.statnews.com/category/politics/) * [Science](https://www.statnews.com/category/in-the-lab/) * [First Opinion](https://www.statnews.com/category/first-opinion/) * [STAT+](https://www.statnews.com/topic/stat-plus/) * [STAT Events](https://www.statnews.com/events/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) Search * [Log In](https://www.statnews.com/login/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [My Account](https://www.statnews.com/my-account/) [Home](https://www.statnews.com/) News * [Latest](https://www.statnews.com/latest/) * [Series & Investigations](https://www.statnews.com/stat-series-and-investigations-award-winning-journalism/) * Business * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Health Insurance](https://www.statnews.com/category/insurance/) * [Hospitals](https://www.statnews.com/category/hospitals/) * [Medical Devices](https://www.statnews.com/topic/medical-devices/) * Washington * [Policy](https://www.statnews.com/category/politics/) * [FDA](https://www.statnews.com/topic/fda/) * [NIH](https://www.statnews.com/topic/nih/) * Science * [CRISPR](https://www.statnews.com/topic/crispr/) * [Gene Therapy](https://www.statnews.com/topic/gene-therapy/) * [Neuroscience](https://www.statnews.com/topic/neuroscience/) * Public Health * [Addiction](https://www.statnews.com/topic/addiction/) * [Covid-19](https://www.statnews.com/topic/coronavirus/) * [Abortion](https://www.statnews.com/topic/abortion/) * [Health Disparities](https://www.statnews.com/topic/health-disparities/) * [Infectious Disease](https://www.statnews.com/topic/infectious-disease/) * [Mental Health](https://www.statnews.com/topic/mental-health/) * Disease * [Cancer](https://www.statnews.com/topic/cancer/) * [Cardiovascular Disease](https://www.statnews.com/topic/cardiovascular-disease/) * [Chronic Disease](https://www.statnews.com/topic/chronic-disease/) * [Diabetes](https://www.statnews.com/topic/diabetes/) * [Alzheimer's](https://www.statnews.com/topic/alzheimers/) * [Obesity](https://www.statnews.com/topic/obesity/) * Features * [Health Care Costs](https://www.statnews.com/health-insurance-costs-out-of-pocket-out-of-reach-series/) * [The Deadliest Drug](https://www.statnews.com/alcohol-epidemic-hiding-plain-sight-deadliest-drug-series/) * [Science, Shattered](https://www.statnews.com/american-science-shattered/) [Newsletters](https://www.statnews.com/signup/) [Opinion](https://www.statnews.com/category/first-opinion/) Columns * [Adam Feuerstein](https://www.statnews.com/category/adams-take/) * [Matthew Herper](https://www.statnews.com/category/matts-take/) * [Ed Silverman](https://www.statnews.com/category/pharmalot-view/) [Reports](https://reports.statnews.com/) [E-books](https://www.statnews.com/ebooks/) [Podcasts](https://www.statnews.com/podcasts/) [Tools & Trackers](https://www.statnews.com/trackers/) * [CRISPR Tracker](https://www.statnews.com/feature/crispr/tracker/) * [Breakthrough Device Tracker](https://www.statnews.com/feature/stat-plus/breakthrough-device-designation-fda-tracker/) * [Generative AI Tracker](https://www.statnews.com/feature/stat-plus/generative-ai-health-hospitals-tracker/) * [Obesity Drug Tracker](https://www.statnews.com/2023/09/12/new-weight-loss-drug-tracker-novo-nordisk-eli-lilly/) [Events](https://www.statnews.com/events/) * [Upcoming Events](https://www.statnews.com/events#upcoming-events) * [Summits](https://www.statnews.com/stat-summits/) [Community](https://www.statnews.com/community/) * [STAT Wunderkinds 2026](https://www.statnews.com/wunderkinds-nominate/) [Video](https://youtube.com/@Statnews) [Advertise](https://www.statnews.com/advertise/) * [STAT Brand Studio](https://sbs.statnews.com/) What's the word? Test your knowledge with our new weekday mini crossword [ Start solving ](https://www.statnews.com/stat-mini-crossword/) [STAT Plus](https://www.statnews.com/stat-plus/)[Pharma](https://www.statnews.com/category/pharma/) # A Novartis drug cut inflammation. Can it improve heart outcomes? ## The drug, pacibekitug, targets IL-6, a common inflammatory driver * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * Email this article * [Share this article](https://www.statnews.com/2026/08/29/novartis-pacibekitug-inflammation-il6-tourmaline-heart-disease/?utm_campaign=rss) ![](https://www.statnews.com/wp-content/uploads/2026/08/AdobeStock_508908319_Editorial_Use_Only-645x645.jpeg) Adobe ![](https://www.statnews.com/wp-content/uploads/2021/02/andrew-j-avatar-small-1-80x80.png) By [Andrew Joseph](https://www.statnews.com/staff/andrew-joseph/) Aug. 29, 2026 Europe Correspondent ![](https://www.statnews.com/wp-content/uploads/2021/02/andrew-j-avatar-small-1-80x80.png) [Andrew Joseph](https://www.statnews.com/staff/andrew-joseph/) 1. [](https://x.com/DrewQJoseph "X") andrew.joseph@statnews.com Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. A newly acquired Novartis drug successfully lowered signs of inflammation in a midstage study, as experts wait to hear how the company plans to advance the drug as a potential cardiovascular treatment. In the Phase 2 TRANQUILITY study, the drug, pacibekitug, led to sustained decreases in biomarkers of inflammation, according to results presented Saturday at the European Society of Cardiology’s annual meeting in Munich. Investigators reported a dose-dependent drop in biomarker levels on certain measures, meaning higher doses led to greater reductions, a sign the drug is having an effect. Advertisement Pacibekitug is an antibody that targets IL-6, or interleukin-6, a protein involved in regulating immune responses. STAT+ Exclusive Story Already have an account? [Log in](https://www.statnews.com/login/) ![STAT+](https://www.statnews.com/wp-content/themes/stat/images/stat-plus-breaker-bg.png) [ ![STAT+](https://www.statnews.com/wp-content/themes/stat/images/stat-plus-logo-white.svg) ](https://www.statnews.com/stat-plus/) ## This article is exclusive to STAT+ subscribers ### Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+. Already have an account? [Log in](https://www.statnews.com/login/) Individual plans Group plans Monthly $39 Totals $468 per year [$39/month](https://www.statnews.com/stat-plus/subscribe/?plan=stat-plus-monthly-39-0) [Get Started](https://www.statnews.com/stat-plus/subscribe/?plan=stat-plus-monthly-39-0) Totals $468 per year Starter $30 for 3 months, then $399/year [$30 for 3 months](https://www.statnews.com/stat-plus/subscribe/?plan=3mo30_yearly_pw) [Get Started](https://www.statnews.com/stat-plus/subscribe/?plan=3mo30_yearly_pw) Then $399/year Annual $399 Save 15% [$399/year](https://www.statnews.com/stat-plus/subscribe/?plan=stat-plus-annually-399-0) [Get Started](https://www.statnews.com/stat-plus/subscribe/?plan=stat-plus-annually-399-0) Save 15% 11+ Users Custom Savings start at 25%! [Request A Quote](https://www.statnews.com/stat-plus/group-subscriptions/) [Request A Quote](https://www.statnews.com/stat-plus/group-subscriptions/) Savings start at 25%! 2-10 Users $300 Annually per user [$300/year](https://www.statnews.com/stat-plus/subscribe/?plan=stat_plus_groups_self_serve_0) [Get Started](https://www.statnews.com/stat-plus/subscribe/?plan=stat_plus_groups_self_serve_0) $300 Annually per user [View All Plans](https://www.statnews.com/stat-plus/) [![STAT+](https://www.statnews.com/wp-content/themes/stat/images/stat-plus-logo.svg)](https://www.statnews.com/stat-plus/) To read the rest of this story subscribe to STAT+. [Subscribe](https://www.statnews.com/stat-plus/) [Log In](https://www.statnews.com/login/) [cardiology](https://www.statnews.com/topic/cardiology/), [drug development](https://www.statnews.com/topic/drug-development/), [Pharmaceuticals](https://www.statnews.com/topic/pharmaceuticals/), [STAT+](https://www.statnews.com/topic/stat-plus/) [Submit a correction request](https://www.statnews.com/contact/?how_can_we_help_=Editorial%20Correction%20Request)[Reprints](https://www.parsintl.com/publications/stat/) 1. ![](https://www.statnews.com/wp-content/uploads/2021/02/andrew-j-avatar-small-1-80x80.png) [Andrew Joseph](https://www.statnews.com/staff/andrew-joseph/) 1. [](https://x.com/DrewQJoseph "X") 2. Europe Correspondent 1. [](https://x.com/DrewQJoseph "X") 2. Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. ![](https://www.statnews.com/wp-content/themes/stat/images/article-new/envelope-open.svg) ![](https://www.statnews.com/wp-content/uploads/2023/06/Morning-Rounds-Logo-Black-640x295.png) ### Newsletter Understand how science, health policy, and medicine shape the world every day Please enter a valid email address. Sign Up Your data will be processed in accordance with our [Privacy Policy](https://www.statnews.com/privacy/) and [Terms of Service](https://www.statnews.com/terms-conditions/). You may opt out of receiving STAT communications at any time. Advertisement Most Popular 1. ![](https://www.statnews.com/wp-content/uploads/2026/08/GettyImages-1317445583-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [In autopsy of failed heart disease study, AstraZeneca raises broader questions about silencer drugs](https://www.statnews.com/2026/08/28/astrazeneca-ionis-wainua-eplontersen-attr-cm-study-failure-bridgebio-alnylam/) 2. ![](https://www.statnews.com/wp-content/uploads/2026/07/AP26210452356034-80x80.jpg) [Fauci invokes Fifth Amendment in declining to answer questions before Senate panel](https://www.statnews.com/2026/07/29/fauci-pleads-fifth-criticizes-rand-paul-senate-hearing/) 3. ![](https://www.statnews.com/wp-content/uploads/2026/08/AdobeStock_578977705-80x80.jpeg) [AAP president: How pediatricians are navigating federal leaders’ fearmongering on vaccines](https://www.statnews.com/2026/08/14/vaccine-executive-order-policy-aap-president/) 4. ![](https://www.statnews.com/wp-content/uploads/2025/03/GettyImages-1227710555-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [FDA rejects Capricor’s cell therapy for Duchenne muscular dystrophy](https://www.statnews.com/2025/07/11/fda-rejects-capricors-cell-therapy-for-duchenne-muscular-dystrophy/) 5. ![](https://www.statnews.com/wp-content/uploads/2024/04/42301616611_d33b1c01d4_k-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Exact Sciences reports initial positive results in colon cancer blood test, but pivot trial still pending](https://www.statnews.com/2024/09/16/exact-sciences-liquid-biopsy-colon-cancer-test-early-data/) #### [ Reports ](https://reports.statnews.com/) [ ![](https://www.statnews.com/wp-content/uploads/2026/08/2026_CancerReport_ReportCover-328x424.jpg) Explore Cancer’s transformational moments: KRAS, CAR-T, immunotherapy, and more ](https://reports.statnews.com/products/cancer-transformational-moments-advances-in-kras-car-t-immunotherapy) Advertisement #### [Events](https://www.statnews.com/events/) [ ![](https://www.statnews.com/wp-content/uploads/2026/07/924_Samsung_VirtualEvent_Wordpress_FeaturedImage-80x80.jpg) Biosimilars: Have We Reached an Inflection Point? Virtual Sep 24 ](https://www.statnews.com/event/biosimilars-what-is-next-virtual-event-sept-2026/) [ ![](https://www.statnews.com/wp-content/uploads/2026/01/Flagship2026_Wordpress_CalendarImageRegGoLive-1-80x80.jpg) 2026 STAT Summit Boston, MA Oct 14 ](https://www.statnews.com/event/2026-stat-summit/) [ ![](https://www.statnews.com/wp-content/uploads/2026/07/2026_DD_OfficeHours_VirtualEvent_Wordpress_CalendarImage-80x80.jpg) Office Hours with Isabella Cueto and Lev Facher Virtual Jul 29 ](https://www.statnews.com/event/deadliest-drug-series-office-hours-ama-july-2026/) Most Read in [STAT+](https://www.statnews.com/stat-plus/) 1. ![](https://www.statnews.com/wp-content/uploads/2026/08/image-15-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Inside Moderna and Merck’s cancer vaccine triumph](https://www.statnews.com/2026/08/24/inside-moderna-and-merck-cancer-vaccine-triumph/) 2. ![](https://www.statnews.com/wp-content/uploads/2026/08/Revmed_campus2-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [FDA approves new pancreatic cancer drug expected to usher in new era of treatment](https://www.statnews.com/2026/08/26/pancreatic-cancer-drug-rasonque-approved/) 3. ![](https://www.statnews.com/wp-content/uploads/2026/08/F0372048-Lipoprotein_A_particle_illustration-1-e1787689211295-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [New treatments for common cardiovascular risk factor near the market, with billions at stake](https://www.statnews.com/2026/08/26/lp-a-drugs-novartis-amgen-lilly-potential-heart-disease-blockbuster/) 4. ![](https://www.statnews.com/wp-content/uploads/2026/08/GettyImages-2270934863-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Comments on OMB research rule mysteriously removed from federal website](https://www.statnews.com/2026/08/25/russell-vought-omb-funding-comments-daughter-benefited-nih-research/) 5. ![](https://www.statnews.com/wp-content/uploads/2026/08/LongLab_Immunofluorescence-of-the-biosynthetic-enzyme-for-exercise-inducible-Lac-Phe-Cndp2-green-and-nuclei-DAPI-blue-in-mouse-gut-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [A pill that mimics exercise? Early results on drug designed to maintain both weight loss and muscle mass](https://www.statnews.com/2026/08/18/enveda-pill-mimics-exercise-phase-one-trial-leptin-weight-loss-maintenance/) #### Recommended ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Health Health August 28, 2026 ### [ Juul gets OK to sell updated vaping device with age-gating technology ](https://www.statnews.com/2026/08/28/juul-fda-clearance-updated-ecigarette-age-gating-technology/) By Associated Press ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) First Opinion First Opinion August 28, 2026 ### [ The unintended consequences of the Lindsay Clancy case ](https://www.statnews.com/2026/08/28/lindsay-clancy-postpartum-psychosis-reproductive-psychiatrists-liability/) By Renee Sorrentino and Susan Hatters Friedman Advertisement ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Pharmalot Pharmalot August 28, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Up and down the ladder: The latest comings and goings ](https://www.statnews.com/pharmalot/2026/08/28/up-down-ladder-latest-comings-goings-jobs-pharma-biotech/) By [Ed Silverman](https://www.statnews.com/staff/ed-silverman/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) The Readout The Readout August 28, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: AstraZeneca and Ionis detail surprise failure of heart disease drug, with Alnylam closely watching ](https://www.statnews.com/2026/08/28/biotech-news-astrazeneca-ionis-detail-surprise-failure-of-heart-disease-drug/) By [Meghana Keshavan](https://www.statnews.com/staff/meghana-keshavan/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Morning Rounds Morning Rounds August 28, 2026 ### [ At a federal autism advisory committee meeting, members double down on long-debunked theories ](https://www.statnews.com/2026/08/28/health-news-federal-autism-adcomm-doubles-down-on-debunked-theory/) By [O. Rose Broderick](https://www.statnews.com/staff/rose-broderick/) #### Subscriber Picks 1. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Inside Moderna and Merck’s cancer vaccine triumph ](https://www.statnews.com/2026/08/24/inside-moderna-and-merck-cancer-vaccine-triumph/) By [Matthew Herper](https://www.statnews.com/staff/matthew-herper/), [Jason Mast](https://www.statnews.com/staff/jason-mast/), and [Angus Chen](https://www.statnews.com/staff/angus-chen/) 2. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: FDA approves new pancreatic cancer drug expected to usher in new era of treatment ](https://www.statnews.com/2026/08/26/pancreatic-cancer-drug-rasonque-approved/) By [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) and [Angus Chen](https://www.statnews.com/staff/angus-chen/) 3. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: When it comes to women’s health, money talks ](https://www.statnews.com/2026/08/26/womens-health-reverse-pitch-profit-driven-approach-endometriosis-osteoporosis/) By [Elizabeth Cooney](https://www.statnews.com/staff/elizabeth-cooney/) 4. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: HHS document offers new clues to Kennedy’s vaccine plans ](https://www.statnews.com/2026/08/21/rfi-reveals-possible-kennedy-strategy-vaccine-policy-changes/) By [Chelsea Cirruzzo](https://www.statnews.com/staff/chelsea-cirruzzo/) 5. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Capricor Therapeutics' Duchenne treatment is heading for an FDA rejection ](https://www.statnews.com/2026/08/20/capricor-th
## Related Clinical Research

- [AstraZeneca and Ionis Explain Unexpected Failure of Heart-Disease Drug as Alnylam Watches](https://medichelpline.com/clinical-feed/stat-news-1-stat-astrazeneca-and-ionis-detail-surprise-failure-of-heart-disease-drug-with.md)
- [AstraZeneca Phase 3 ATTR-CM Trial Fails; FDA Ruling Ends GLP-1 Shortage Claims](https://medichelpline.com/clinical-feed/stat-news-3-stat-pharmalittle-we-re-reading-about-an-astrazeneca-trial-failure-a-monstrous.md)
- [Sprint intervals boost heart-protective proteins more than moderate cycling, study finds](https://medichelpline.com/clinical-feed/medical-news-today-0-sprints-or-endurance-study-finds-short-workouts-release-heart-protective.md)
- [Which Exercises Best Target Blood Pressure, Blood Sugar, and Cholesterol in Metabolic Syndrome?](https://medichelpline.com/clinical-feed/medical-news-today-0-how-do-different-exercises-target-blood-pressure-blood-sugar-and-cholesterol.md)
- [Cardiac-targeted delivery strategies for advanced therapies in heart disease](https://medichelpline.com/clinical-feed/pubmed-42284133.md) (DOI: 10.1093/eurheartj/ehag432)

## Navigation
- [← Back to Cardiology Feed](https://medichelpline.com/clinical-feed/cardiology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.